Takeda announces handful of pipeline cuts in effort to ‘pivot resources’

Nicole DeFeudis

Editor

Takeda revealed a handful of pipeline cuts in its fourth-quarter earnings results on Thursday, as the company focuses its attention on six late-stage programs it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Takeda announces handful of pipeline cuts in effort to ‘pivot resources’

Nicole DeFeudis

Editor

Sign up to read this article for free.

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

GSK awaits Nucala decision after FDA target date passes

'Find a way, or make one': How two scientists hope to revitalize CRISPR's rare disease crisis

AstraZeneca loses appeals court fight over IRA drug price negotiations

AI-focused biotech insitro cuts 22% of staff, citing 'tumultuous market'

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges

Take­da an­nounces hand­ful of pipeline cuts in ef­fort to ‘piv­ot re­sources’

Editor

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Takeda announces handful of pipeline cuts in effort to ‘pivot resources’